JP2011507858A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507858A5 JP2011507858A5 JP2010539514A JP2010539514A JP2011507858A5 JP 2011507858 A5 JP2011507858 A5 JP 2011507858A5 JP 2010539514 A JP2010539514 A JP 2010539514A JP 2010539514 A JP2010539514 A JP 2010539514A JP 2011507858 A5 JP2011507858 A5 JP 2011507858A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- connexin
- polynucleotide
- drug
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US883407P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/014022 WO2009085271A2 (en) | 2007-12-21 | 2008-12-22 | Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507858A JP2011507858A (ja) | 2011-03-10 |
| JP2011507858A5 true JP2011507858A5 (enExample) | 2013-04-25 |
Family
ID=40824956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539514A Pending JP2011507858A (ja) | 2007-12-21 | 2008-12-22 | 整形外科状態の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた、抗コネキシンペプチドの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110243964A1 (enExample) |
| EP (1) | EP2242844A2 (enExample) |
| JP (1) | JP2011507858A (enExample) |
| AU (1) | AU2008343842A1 (enExample) |
| CA (1) | CA2710382A1 (enExample) |
| WO (1) | WO2009085271A2 (enExample) |
| ZA (1) | ZA201005218B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101573131B (zh) | 2005-02-03 | 2017-12-01 | 科达治疗有限公司 | 抗‑连接蛋白化合物及其治疗应用 |
| PT2049123E (pt) | 2006-08-03 | 2013-03-06 | Horizon Pharma Ag | Tratamento de doença reumatóide com glucocorticóide de libertação retardada |
| CN102920996A (zh) * | 2007-12-11 | 2013-02-13 | 科达治疗公司 | 受损伤口愈合的药物组合物 |
| AU2008343840A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| CA2710380A1 (en) | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin 43 poly nucleotide for the treatment of fibrotic conditions |
| WO2009148613A1 (en) * | 2008-06-04 | 2009-12-10 | Coda Therapeutics, Inc. | Treatment of pain with gap junction modulation compounds |
| MX351881B (es) | 2012-03-01 | 2017-11-01 | Firststring Res Inc | Geles tópicos que contienen péptidos de alfa-conexina c- terminal (act). |
| WO2015027120A1 (en) | 2013-08-21 | 2015-02-26 | Jiang Jean X | Compositions and methods for targeting connexin hemichannels |
| WO2016029191A2 (en) | 2014-08-22 | 2016-02-25 | Auckland Uniservices Limited | Channel modulators |
| AU2017224122B2 (en) | 2016-02-26 | 2024-04-11 | The Board Of Regents Of The University Of Texas System | Connexin (Cx) 43 hemichannel-binding antibodies and uses thereof |
| CN111201247A (zh) | 2017-04-28 | 2020-05-26 | 奥克兰联合服务有限公司 | 治疗方法和新颖构建体 |
| US12138293B2 (en) | 2020-10-22 | 2024-11-12 | Xequel Bio, Inc. | Peptide formulations and ophthalmic uses thereof |
| US12667586B2 (en) | 2023-03-07 | 2026-06-30 | Glaukos Corporation | Treatments for ocular surface disorders |
| AU2024315072A1 (en) * | 2023-08-03 | 2026-01-22 | Osartis Gmbh | Reducing inflammation in surgical site tissues |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7098190B1 (en) * | 1999-01-27 | 2006-08-29 | Coda Therapeutics Ltd. | Formulations comprising antisense nucleotides to connexins |
| JP2003238441A (ja) * | 2002-02-08 | 2003-08-27 | 英行 ▲高▼野 | 血管新生抑制剤 |
| JP2007519756A (ja) * | 2004-01-30 | 2007-07-19 | アンジオテック インターナショナル アーゲー | 拘縮を治療するための組成物および方法 |
| CN101573131B (zh) * | 2005-02-03 | 2017-12-01 | 科达治疗有限公司 | 抗‑连接蛋白化合物及其治疗应用 |
| US7767710B2 (en) * | 2005-05-25 | 2010-08-03 | Calosyn Pharma, Inc. | Method for treating osteoarthritis |
| RU2542471C2 (ru) * | 2006-11-15 | 2015-02-20 | Коуда Терапьютикс, Инк. | Улучшенные способы и композиции для заживления ран |
| CN102920996A (zh) * | 2007-12-11 | 2013-02-13 | 科达治疗公司 | 受损伤口愈合的药物组合物 |
-
2008
- 2008-12-22 US US12/809,980 patent/US20110243964A1/en not_active Abandoned
- 2008-12-22 CA CA2710382A patent/CA2710382A1/en not_active Abandoned
- 2008-12-22 WO PCT/US2008/014022 patent/WO2009085271A2/en not_active Ceased
- 2008-12-22 AU AU2008343842A patent/AU2008343842A1/en not_active Abandoned
- 2008-12-22 JP JP2010539514A patent/JP2011507858A/ja active Pending
- 2008-12-22 EP EP08868893A patent/EP2242844A2/en not_active Withdrawn
-
2010
- 2010-07-21 ZA ZA2010/05218A patent/ZA201005218B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507860A5 (enExample) | ||
| JP2011507861A5 (enExample) | ||
| JP2011507855A5 (enExample) | ||
| JP2011506447A5 (enExample) | ||
| Thiede et al. | Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica) | |
| JP2009544585A5 (enExample) | ||
| JP4817495B2 (ja) | 外因性カンナビノイドでの痛みの制御 | |
| JP2005512976A5 (enExample) | ||
| CN109477109A (zh) | 靶向人lmna的寡核苷酸类似物 | |
| JP2011507856A5 (enExample) | ||
| JP2006515351A5 (enExample) | ||
| JP2011507859A5 (enExample) | ||
| JP2009519949A5 (enExample) | ||
| EP2139457A2 (en) | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
| Mitchell et al. | Reversal of parkinsonian symptoms by intrastriatal and systemic manipulations of excitatory amino acid and dopamine transmission in the bilateral 6-OHDA lesioned marmoset | |
| JP2024506435A5 (enExample) | ||
| JP2024521091A (ja) | 褐色脂肪生成を誘導する方法及び組成物 | |
| CN107847565A (zh) | 用于肌肉减少症治疗的包括胰高血糖素样肽‑1 受体激动剂的药物组合物 | |
| WO2009150214A3 (en) | Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease | |
| CN112156104B (zh) | 一种治疗抑郁症的药物 | |
| Chen et al. | Systemic penicillin as an experimental model of epilepsy | |
| IL194500A (en) | A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above | |
| Bufalari et al. | Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial | |
| JPH07508003A (ja) | 非経口投与用の安定化ソマトトロピン | |
| EP2127681A1 (en) | Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |